South Korea vs Middle East, North Africa, Afghanistan & Pakistan: Immunization, HepB3
Immunization, HepB3 over time
- South Korea
- Middle East, North Africa, Afghanistan & Pakistan
How they compare
South Korea currently reports 97.0% against 84.4% in Middle East, North Africa, Afghanistan & Pakistan, a difference of 12.6%.
That makes South Korea's figure about 1.1 times Middle East, North Africa, Afghanistan & Pakistan's.
Across all 30 years both countries report, South Korea has been ahead every year.
South Korea ranks 26th and Middle East, North Africa, Afghanistan & Pakistan ranks 24th of 188 countries.
South Korea has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | South Korea | Middle East, North Africa, Afghanistan & Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 90.0% | 32.7% | 57.3% | South Korea |
| 2000s | 93.4% | 63.5% | 29.9% | South Korea |
| 2010s | 98.0% | 80.5% | 17.5% | South Korea |
| 2020s | 97.4% | 83.4% | 14.0% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, South Korea or Middle East, North Africa, Afghanistan & Pakistan?
- South Korea, at 97.0% against 84.4% in Middle East, North Africa, Afghanistan & Pakistan as of 2024.
- What is the difference in immunization, hepb3 between South Korea and Middle East, North Africa, Afghanistan & Pakistan?
- 12.6%, with South Korea ahead.
- How many years of comparable data are there for South Korea and Middle East, North Africa, Afghanistan & Pakistan?
- 30 years are reported by both, from 1995 to 2024.
- How do South Korea and Middle East, North Africa, Afghanistan & Pakistan rank globally for immunization, hepb3?
- South Korea ranks 26th and Middle East, North Africa, Afghanistan & Pakistan ranks 24th of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.